Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-05
1999-07-27
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31445
Patent
active
059290919
ABSTRACT:
The present invention comprises a method of lowering plasma levels of Lp(a) in animals by administering an effective Lp(a)-reducing amount of a microsomal triglyceride transfer protein inhibitor of the structural formula: ##STR1## or a pharmaceutically acceptable salt thereof, wherein R.sup.1 is alkyl, alkenyl alkynyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, cycloalkyl, or cycloalkylalkyl, each of which is independently optionally substituted through available carbon atoms with 1, 2, or 3 groups selected from halo, alkyl, alkenyl, alkoxy, aryloxy, aryl, arylalkyl, alkylmercapto, arylmercapto, cycloalkyl, cycloalkylalkyl, heteroaryl, and heteroarylalkyl. By lowering Lp(a) levels, the animals are protected against developing premature atherosclerosis and consequent cardiovascular and cerebrovascular diseases.
REFERENCES:
patent: 5595872 (1997-01-01), Wetterau, II et al.
Lee Helen Tsenwhei
Ramharack Randy Ranjee
Ashbrook Charles W.
Jordan Kimberly
Warner-Lambert & Company
LandOfFree
Method of lowering plasma levels of lipoprotein(a) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of lowering plasma levels of lipoprotein(a), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of lowering plasma levels of lipoprotein(a) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-879061